Почетна › Dijabetes tipa 2 › Тенеси
Kliničke studije za Dijabetes tipa 2 u državi Тенеси
20 studija za Dijabetes tipa 2 traži učesnike na lokacijama u državi Тенеси.
Gradovi u državi Тенеси
Zvanični tekst studije (na engleskom)
A Study Evaluating the Safety of Inavolisib and Fulvestrant With or Without Palbociclib in Participants With Advanced Breast Cancer (ABC) and Type 2 Diabetes
- West Cancer Center & Research Institute, Germantown
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 13. 11. 2026. · NCT07748208A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
- University Diabetes & Endocrine Consultants, Chattanooga
- LifeDoc Research, PLLC, Memphis
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 13. 11. 2026. · NCT07754461EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- Alliance for Multispecialty Research, LLC-Knoxville-69693, Knoxville
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT07064473Gut Microbiota in Metabolic Surgery
- Vanderbilt_University MC, Nashville
Тражи се учесникОпсервациона студија
Узраст од 21 до 65 · Оба пола · Ажурирано 9. 11. 2026. · NCT05000996A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
- Research Site, Franklin
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 9. 11. 2026. · NCT07776509A Study of Orforglipron (LY3502970) Compared With Dulaglutide in Pediatric Participants With Type 2 Diabetes
- Vanderbilt Health One Hundred Oaks, Nashville
Тражи се учесникФаза 3
Узраст од 10 до 17 · Оба пола · Ажурирано 5. 11. 2026. · NCT07668336A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus
- Research Site, Kingsport
- Research Site, Nashville
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 30. 10. 2026. · NCT07662109A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
- Research Site, Franklin
- Research Site, Jackson
- Research Site, Knoxville
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 28. 10. 2026. · NCT07784270A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
- Research Site, Memphis
- Research Site, Morristown
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 22. 10. 2026. · NCT07662213A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes
- LifeDoc Health, Memphis
Тражи се учесникФаза 3
Узраст од 10 до 18 · Оба пола · Ажурирано 19. 10. 2026. · NCT07282613A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes
- LifeDoc Health, Memphis
Тражи се учесникФаза 2
Узраст од 18 до 75 · Оба пола · Ажурирано 7. 10. 2026. · NCT07668388Research Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to Cagrisema
- Clinical Research Associates, Nashville
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 30. 9. 2026. · NCT07817251A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
- Community DPC, Cleveland
- University of Tennessee Medical Center, Knoxville
- TriStar Centennial Medical Center (HCA Health Care), Nashville
Тражи се учесникЗдраве особе су добродошле
Узраст 55 и старији · Оба пола · Ажурирано 28. 9. 2026. · NCT06112418A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
- AURORA-2 Clinical Site, Memphis
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 16. 9. 2026. · NCT07743450A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes
- CNS Healthcare, Memphis
Тражи се учесникФаза 2
Узраст од 18 до 75 · Оба пола · Ажурирано 11. 9. 2026. · NCT07415954AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
- Holston Medical Group Pc, Bristol
- The Alliance for Multispecialty Research LLC AMR, Knoxville
- MidState Endocrine Associates, Nashville
Тражи се учесникФаза 3
Узраст 45 и старији · Оба пола · Ажурирано 1. 9. 2026. · NCT07797335A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes Mellitus
- Research Site, Knoxville
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 31. 8. 2026. · NCT07662044A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus on Background Insulin
- Research Site, Memphis
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 4. 8. 2026. · NCT07664553Evaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes
- University of Diabetes and Endocrine Consultants, Chattanooga
Тражи се учесник
Узраст од 18 до 75 · Оба пола · Ажурирано 3. 8. 2026. · NCT07521475Continuous Glucose Monitoring for Outpatient Diabetes Management After Hospital Discharge
- Vanderbilt University Medical Center, Nashville
Тражи се учесник
Узраст 18 и старији · Оба пола · Ажурирано 5. 3. 2026. · NCT06852950Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.